Skip to content
Screener

Arbutus Biopharma Corporation ABUS Deferred Income Revenue Recognized

Deferred Income Revenue Recognized at other companies

MetLife logo
MetLifeMET
$1M0.0%
MetLife logo
MetLifeMET
$59M-6.3%
MetLife logo
MetLifeMET
$20M+5.3%
MetLife logo
MetLifeMET
$33M+13.8%
MetLife logo
MetLifeMET
$1M0.0%
Ameriprise Financial logo
Ameriprise FinancialAMP
$0—

Segments

By product

See full
Labor hours$800K—

Other financials

Income statement

See full
Revenue$179.1M+10,055%
Operating income$168.9M+757%
Net income$169.7M+792%
EPS (diluted)$0.87+769%

Balance sheet

See full
Cash & equivalents$23.7M-36.1%
Total debt$631.0K-46.9%
Total equity$260.2M+229%
Total assets$277.2M+137%

Cash flow

See full
Operating cash flow-$8.1M+39.4%
CapEx--100%
Free cash flow-$4.7M+55.0%

Valuation

See full
Market cap$914.6M+42.4%
Enterprise value$891.52M+47.1%
P/E5.7×—
P/S4.8×-36.9×

Profitability

See full
Operating margin81.7%+42.1pp
Net margin84%+43.4pp
FCF margin-281.5%-119pp

Returns & leverage

See full
Return on equity94.7%+65.1pp
Debt / equity0×0.0×
Current ratio54.3×+48.3×